J Korean Ophthalmol Soc > Volume 49(2); 2008 > Article
Journal of the Korean Ophthalmological Society 2008;49(2):303-308.
DOI: https://doi.org/10.3341/jkos.2008.49.2.303    Published online February 29, 2008.
Clinical Analysis of Successfully Treated Amblyopia with Anisometropia, Strabismis, and Combined Cause.
Eun Kyung Kim, Mi Young Choi, Yeon Hui Kim
1Department of Ophthalmology, Chungbuk National University College of Medicine, Cheongju, Korea. mychoi@chungbuk.ac.kr
2Chungbuk National University Medical Research Institute, Cheongju, Korea.
약시 치료에 성공한 굴절부등약시, 사시약시, 혼합약시의 임상분석
김은경ㆍ최미영ㆍ김연희
"Department of Ophthalmology, Chungbuk National University College of Medicine, Cheongju, Korea Chungbuk National University Medical Research Institute, Cheongju, Korea"
Correspondence:  Eun Kyung Kim, M.D.
Abstract
PURPOSE
To evaluate the duration of therapy in amblyopic children with anisometropia and/or strabismus who had been successfully treated with a best corrected visual acuity (BCVA) of 1.0. METHODS: The duration of amblyopic treatment was compared according to the cause of amblyopia (anisometropia, strabismus, combined), the initial BCVA of amblyopic eye, the age at treatment, and the prediction of a further duration of treatment needed. RESULTS: The mean age of amblyopic treatment in 66 amblyopic children with anisometropia and strabismus was 5.4 years and the mean duration of treatment to gain BCVA of 1.0 was 15.9 months. The duration of treatment was longer in children with initially poorer BCVA and in younger aged children than in older aged children at diagnosis. However, there was no statistical significance according to the cause of amblyopia. In occlusion therapy, the patching time from the initial BCVA to 1.0 was not statistically different from the patching time from the midpoint VA (between the initial visual acuity and 1.0) to 1.0. CONCLUSIONS: The duration of treatment to gain a VA of 1.0 was dependent on the degree of the initial BCVA in the amblyopic eye and the age at treatment. In occlusion therapy, the duration of further treatment to gain a BCVA of 1.0 was necessary as much as the duration to gain a midpoint VA from the initial BCVA.
Key Words: Amblyopia;Anisometropia;Occlusion;Strabismus


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next